Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer

PURPOSE: To analyze the plasma lipid spectrum between healthy control and patients with pancreatic cancer and to select differentially expressed tumor markers for early diagnosis. METHODS: In total, 20 patents were divided into case group and healthy control group according to surgical pathology. Of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Dehua, Mu, Di, Cheng, Ming, Dou, Yuting, Zhang, Xianwei, Feng, Zhensheng, Qiu, Guangting, Yu, Hua, Chen, Yang, Xu, Hong, Sun, Jian, Zhou, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 2020
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341992/
https://www.ncbi.nlm.nih.gov/pubmed/32638847
http://dx.doi.org/10.1590/s0102-865020200050000008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341992/
https://www.ncbi.nlm.nih.gov/pubmed/32638847
http://dx.doi.org/10.1590/s0102-865020200050000008

Ejemplares similares